Silo Pharma, Inc. (SILO)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 12:12PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 3.52M |
| Enterprise Value | -3.22M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 39.83 |
| Price/Book (mrq) | 0.67 |
| Enterprise Value/Revenue | -28.26 |
| Enterprise Value/EBITDA | 0.56 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.46 |
| 52-Week Change 3 | -54.09% |
| S&P500 52-Week Change 3 | 25.87% |
| 52 Week High 3 | 3.0500 |
| 52 Week Low 3 | 0.9000 |
| 50-Day Moving Average 3 | 1.5713 |
| 200-Day Moving Average 3 | 1.6006 |
Share Statistics
| Avg Vol (3 month) 3 | 279.25k |
| Avg Vol (10 day) 3 | 93.12k |
| Shares Outstanding 5 | 3.69M |
| Implied Shares Outstanding 6 | 3.69M |
| Float 8 | 2.63M |
| % Held by Insiders 1 | 5.97% |
| % Held by Institutions 1 | 3.06% |
| Shares Short (Jun 14, 2024) 4 | 134.77k |
| Short Ratio (Jun 14, 2024) 4 | 0.45 |
| Short % of Float (Jun 14, 2024) 4 | 3.84% |
| Short % of Shares Outstanding (Jun 14, 2024) 4 | 3.66% |
| Shares Short (prior month May 15, 2024) 4 | 107.22k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:50 |
| Last Split Date 3 | Sept 15, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -4,879.14% |
Management Effectiveness
| Return on Assets (ttm) | -27.36% |
| Return on Equity (ttm) | -47.86% |
Income Statement
| Revenue (ttm) | 72.1k |
| Revenue Per Share (ttm) | 0.02 |
| Quarterly Revenue Growth (yoy) | 0.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -3.53M |
| Diluted EPS (ttm) | -1.1700 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.74M |
| Total Cash Per Share (mrq) | 2.41 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.87 |
| Book Value Per Share (mrq) | 1.87 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3.37M |
| Levered Free Cash Flow (ttm) | -2.12M |
© 2024 Yahoo. All rights reserved.